SUO 2020 GU Malignancies Prostate - Results from #20

Viewing 21-30 of 30 articles

SUO 2020: Resetting the Active Surveillance Clock: Apalutamide in Lower Risk Prostate Cancer

SUO 2020: Results from the PROfound Study, A New Second Line Therapy for mCRPC

SUO 2020: Debate: Relugolix for Advanced Prostate Cancer is the New Standard (The HERO Study)

SUO 2020: New Second Line Therapy for mCRPC: PARPi: Results from the PROfound Study

SUO 2020: Non-Metastatic Castration-Resistant Prostate Cancer – The PROSPER Trial Update

SUO 2020: Cause of Death During Prostate Cancer Survivorship: A Contemporary US Population-Based Analysis

SUO 2020: Targeted Versus Systematic Prostate Biopsy

SUO 2020: Increasing Enrollment of Underrepresented Populations in Clinical Trials

SUO 2020: Young Urologic Oncologists Paper of the Year Presentation: Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy - The PREVENTER Randomized Clinical Trial

SUO 2020: Developing Trials to Answer the Unanswered Questions

1
2